Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Migliore

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Joint Bone Spine|June 4, 2023
Intra-articular injections of biological disease-modifying anti-rheumatic drugs in inflammatory arthropathies: An up-to-date narrative reviewSuhel G Al Khayyat, Edoardo Conticini, Paolo Falsetti, et al.
Therapeutic Advances in Musculoskeletal Disease|June 9, 2021
Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO groupThierry Conrozier, Raghu Raman, Xavier Chevalier, et al.
Cartilage|June 22, 2018
EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in OsteoarthritisThierry Conrozier, Jordi Monfort, Xavier Chevalier, et al.
Cartilage|March 29, 2025
EUROVISCO Good Medical Practice Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Knee OsteoarthritisJordi Monfort, Yves Henrotin, Xavier Chevalier, et al.
Internal and Emergency Medicine|March 5, 2016
Vitamin D deficiency in patients with either rheumatic diseases or inflammatory bowel diseases on biologic therapyVincenzo Bruzzese, Angelo Zullo, Andrea Picchianti Diamanti, et al.
Cartilage|November 20, 2024
EUROVISCO Consensus Guidelines for the Use of Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis Based on Patient CharacteristicsThierry Conrozier, Raghu Raman, Demirhan Diraçoglu, et al.
Cartilage|February 9, 2026
EUROVISCO Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Hip OsteoarthritisAlberto Migliore, Raghu Raman, Demirhan Diraçoglù, et al.
European Journal of Physical and Rehabilitation Medicine|May 21, 2019
Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in ItalyAndrea Bernetti, Massimiliano Mangone, Ciro Villani, et al.
International Journal of Environmental Research and Public Health|November 13, 2021
Italian Expert Consensus on Clinical and Therapeutic Management of Multiple Chemical Sensitivity (MCS)Giovanni Damiani, Marco Alessandrini, Daniela Caccamo, et al.
Arthritis Care & Research|April 19, 2012
Socioeconomic burden of total joint arthroplasty for symptomatic hip and knee osteoarthritis in the Italian population: a 5-year analysis based on hospitalization recordsP Piscitelli, G Iolascon, G Di Tanna, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Joint Bone Spine|June 4, 2023
Intra-articular injections of biological disease-modifying anti-rheumatic drugs in inflammatory arthropathies: An up-to-date narrative reviewSuhel G Al Khayyat, Edoardo Conticini, Paolo Falsetti, et al.
Therapeutic Advances in Musculoskeletal Disease|June 9, 2021
Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO groupThierry Conrozier, Raghu Raman, Xavier Chevalier, et al.
Cartilage|June 22, 2018
EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in OsteoarthritisThierry Conrozier, Jordi Monfort, Xavier Chevalier, et al.
Cartilage|March 29, 2025
EUROVISCO Good Medical Practice Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Knee OsteoarthritisJordi Monfort, Yves Henrotin, Xavier Chevalier, et al.
Internal and Emergency Medicine|March 5, 2016
Vitamin D deficiency in patients with either rheumatic diseases or inflammatory bowel diseases on biologic therapyVincenzo Bruzzese, Angelo Zullo, Andrea Picchianti Diamanti, et al.
Cartilage|November 20, 2024
EUROVISCO Consensus Guidelines for the Use of Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis Based on Patient CharacteristicsThierry Conrozier, Raghu Raman, Demirhan Diraçoglu, et al.
Cartilage|February 9, 2026
EUROVISCO Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Hip OsteoarthritisAlberto Migliore, Raghu Raman, Demirhan Diraçoglù, et al.
European Journal of Physical and Rehabilitation Medicine|May 21, 2019
Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in ItalyAndrea Bernetti, Massimiliano Mangone, Ciro Villani, et al.
International Journal of Environmental Research and Public Health|November 13, 2021
Italian Expert Consensus on Clinical and Therapeutic Management of Multiple Chemical Sensitivity (MCS)Giovanni Damiani, Marco Alessandrini, Daniela Caccamo, et al.
Arthritis Care & Research|April 19, 2012
Socioeconomic burden of total joint arthroplasty for symptomatic hip and knee osteoarthritis in the Italian population: a 5-year analysis based on hospitalization recordsP Piscitelli, G Iolascon, G Di Tanna, et al.
Pageof 10